Overview
Status
Active
Registry date
2020-11-09
Share capital
2,402,500.00 PLN
Registered address
al. Wojska Polskiego 8, 70-471 Szczecin, Poland
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 52 days early. All were audited by a statutory auditor.
- 202511/06/2026
- 202422/05/2025
- 202302/07/2024
- 202223/03/2023
- 202101/06/2022
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 1.03mMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD -187.92kMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 982.95kMedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 887.63kMedianUSD 609.79kAverageUSD 11.85m
Industry
Authorized Representatives
Amolrat Pracharktam – Management Board Member
Lindsay Jon Brown – President of the Management Board
Torn Pracharktam – President of the Management Board
Manner of representation
Two members of the management board acting jointly are authorized to represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Thai Optical Group Public Company Limited | 4,805 | $648,973.53 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-11-19.
98 1600 1462 1863 6283 0000 0002
71 1600 1462 1863 6283 0000 0003
28 1600 1462 1863 6283 0000 0001
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Medicavera Dahlhausen Groupsp. z o.o. | $7,393,838.95 | medicavera.pl | ||
| LM Linesp. z o.o. | $3,541,531.01 | lmline.pl | ||
| Novartagsp. z o.o. | $2,269,221.93 | novartag.pl | ||
| Medpipesp. z o.o. | $1,191,948.44 | medpipe.pl | ||
| Zbadajsiesp. z o.o. | $1,112,372.08 | labhome.pl | ||
| Medaidsp. z o.o. | $1,034,514.88 | medaid.pl | ||
| Polcoresp. z o.o. | $1,015,341.48 | polcore.pl | ||
| Surgical Solutionssp. z o.o. | $947,852.75 | surgical-solutions.pl | ||
| BL Medicasp. z o.o. + limited partnership | $886,794.58 | blmedica.pl | ||
| BL Medicasp. z o.o. | $148,305.98 | blmedica.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-08-18 | Share capital increase (50,000.00 PLN → 2,402,500.00 PLN) | |
| 2020-11-09 | Entered in the register |
FAQ
The main business activity of TOG Europe focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on November 9, 2020.
The headquarters is located at: Al. Wojska Polskiego 8, 70-471 Szczecin.
The share capital of the company is PLN 2,402,500 (approx. $648,974).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $1,029,866, representing a decrease of 49.6% compared to 2024.
No, the company recorded a net loss of $187,920 in 2025. For comparison, in 2024 the loss was $11,553, representing a multi-fold increase in the loss compared to 2024.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $851,637 in 2025, representing 87% of all operating expenses.
Last updated: 2026-10-07